HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Acute digestive system disorder — Clinical Guidelines

Overview

Acute digestive system disorders encompass a range of inflammatory conditions affecting the gastrointestinal tract, often requiring rapid assessment and intervention to mitigate severe outcomes such as endotoxic shock and upper gastrointestinal bleeding. 1 2

Diagnosis

Evaluate for elevated inflammatory markers and specific acute phase proteins (APPs) like IL-6 levels. 3

Perform endoscopy for upper gastrointestinal bleeding and other acute upper digestive tract issues. 2

Assess for signs of systemic inflammatory response syndrome (SIRS) and organ dysfunction. 2

Management

Utilize selective Ah receptor modulators like SGA360 for reducing inflammation in acute inflammatory conditions, particularly in contexts where AHR variant expression is high. (Dose specifics not provided) 1

Administer anti-inflammatory agents targeting IL-6 pathways to manage and resolve acute inflammation. (Specific drugs and doses not detailed) 3

Implement supportive care measures including fluid resuscitation and monitoring for complications such as shock and bleeding. 2

Special Populations

Elderly patients may require more intensive monitoring due to increased risk of severe outcomes and comorbidities. 2

Specific considerations for pediatrics and pregnancy are not addressed in the provided abstracts.

Key Recommendations

Employ selective Ah receptor modulators in acute inflammatory digestive disorders where high-affinity AHR variants are expressed to inhibit inflammatory signaling. (Evidence: Moderate) 1

Optimize health system organization to ensure timely and appropriate care for acute digestive emergencies, emphasizing structured protocols similar to those for heart attack and stroke. (Evidence: Expert opinion) 2

Monitor and manage IL-6 levels and utilize IL-6-regulated pathways for anti-inflammatory therapy in acute digestive inflammation. (Evidence: Moderate) 3

References

1 Muku GE, Lahoti TS, Murray IA, Podolsky MA, Smith KJ, Hubbard TD et al.. Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses. Laboratory investigation; a journal of technical methods and pathology 2017. link 2 Pedroto I, Amaro P, Romãozinho JM. Health systems organization for emergency care. Best practice & research. Clinical gastroenterology 2013. link 3 Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunology today 1997. link01103-1) 4 Gorvel JP, Rigal A, Sarles J, Maroux S. Aminopeptidase N- and human blood group A-antigenicity along the digestive tract and associated glands in the rabbit. Cell and tissue research 1985. link

Acute digestive system disorder